-
公开(公告)号:US08598200B2
公开(公告)日:2013-12-03
申请号:US13307636
申请日:2011-11-30
IPC分类号: A01N43/42 , A61K31/44 , A01N43/40 , A61K31/445 , A01N43/56 , A61K31/415
CPC分类号: C07D471/04 , C07D487/04
摘要: Compounds of Formula I: wherein X, Y, Z, R1, R2, R3, R4 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.